Therefore, further study focused on specific types of soft-tissue sarcoma is needed to understand the exact role of SIRT1- and DBC1-related pathways in sarcomas and determine the best use of them as therapeutic targets for the treatment of specific types of soft-tissue sarcoma. Here, CCAR2 is linked to soft tissue sarcoma.